scholarly journals Gut microbiome development along the colorectal adenoma–carcinoma sequence

2015 ◽  
Vol 6 (1) ◽  
Author(s):  
Qiang Feng ◽  
Suisha Liang ◽  
Huijue Jia ◽  
Andreas Stadlmayr ◽  
Longqing Tang ◽  
...  
2015 ◽  
Vol 53 (05) ◽  
Author(s):  
A Stadlmayr ◽  
Q Feng ◽  
U Huber-Schönauer ◽  
D Niederseer ◽  
E Aigner ◽  
...  

Gut Microbes ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 1951113
Author(s):  
Yan Hui ◽  
Birgitte Smith ◽  
Martin Steen Mortensen ◽  
Lukasz Krych ◽  
Søren J. Sørensen ◽  
...  

EBioMedicine ◽  
2021 ◽  
Vol 69 ◽  
pp. 103443
Author(s):  
Brooke C. Wilson ◽  
Éadaoin M. Butler ◽  
Celia P. Grigg ◽  
José G.B. Derraik ◽  
Valentina Chiavaroli ◽  
...  

Author(s):  
David B. Healy ◽  
C. Anthony Ryan ◽  
R. Paul Ross ◽  
Catherine Stanton ◽  
Eugene M. Dempsey

2020 ◽  
Author(s):  
Jeremiah Minich ◽  
Barbara Nowak ◽  
Abigail Elizur ◽  
Rob Knight ◽  
Stewart Fielder ◽  
...  

Abstract BackgroundMicrobial succession in vertebrates has primarily focused on vertical transmission and ontogenetic development in the mammalian gut. Teleosts comprise the majority of vertebrate diversity, yet little is known about how the microbiome develops in fish, particularly when vertical transmission is limited or absent for broadcast spawners. Biological factors such as diet, age, phylogeny, and trophic level along with environmental factors such as water salinity, temperature, and depth have been shown to influence the mucosal microbiomes of fish. Here we investigate how various microbial-rich surfaces from the built environment ‘BE’ influence the development of the mucosal microbiome (gill, skin, and digesta) of an economically important marine fish, yellowtail kingfish, Seriola lalandi, over time.ResultsFor the first experiment, we sampled gill and skin microbiomes from 36 fish reared in three tank conditions, and demonstrate that the gill is more influenced by the surrounding environment than the skin. In a second experiment, fish microbiomes (gill, skin, and digesta) and the BE (tank side, water, inlet pipe, airstones, and air diffusers) were sampled from indoor reared fish at three ages (43 dph, 137 dph, 430 dph; n=12 per age). At 430 dph, 20 additional fish were sampled from an outdoor ocean net pen. A total of 304 samples were processed for 16S rRNA gene sequencing. Gill and skin alpha diversity increased while gut diversity decreased with age. Diversity was much lower in fish from the ocean net pen compared to indoor fish. We quantified the change in community dynamics driven by the BE and show that the gill and skin are most influenced by the BE early in development, with aeration equipment having more impact in later ages, while the gut microbiome becomes increasingly differentiated from the environment over time.ConclusionsOur findings suggest that fish mucosal microbiomes are differentially influenced by the built environment with a high turnover and rapid succession occurring in the gill and skin while the gut microbiome is more stable. We demonstrate how individual components of a hatchery system, especially aeration equipment, may contribute directly to microbiome development in a marine fish. In addition, results demonstrate how early life (larval) exposure to stressors in the rearing environment may influence fish microbiome development which is important for animal health and aquaculture production.


2017 ◽  
Vol 30 (4) ◽  
pp. 996-1005 ◽  
Author(s):  
Bei Gao ◽  
Liang Chi ◽  
Ridwan Mahbub ◽  
Xiaoming Bian ◽  
Pengcheng Tu ◽  
...  

2019 ◽  
Vol 8 (2) ◽  
pp. 617-628 ◽  
Author(s):  
Talima Pearson ◽  
J. Gregory Caporaso ◽  
Monica Yellowhair ◽  
Nicholas A. Bokulich ◽  
Megha Padi ◽  
...  

Gut ◽  
2021 ◽  
pp. gutjnl-2020-323476
Author(s):  
Feng Chen ◽  
Xudong Dai ◽  
Chang-Chun Zhou ◽  
Ke-xin Li ◽  
Yu-juan Zhang ◽  
...  

ObjectiveTo profile gut microbiome-associated metabolites in serum and investigate whether these metabolites could distinguish individuals with colorectal cancer (CRC) or adenoma from normal healthy individuals.DesignIntegrated analysis of untargeted serum metabolomics by liquid chromatography-mass spectrometry and metagenome sequencing of paired faecal samples was applied to identify gut microbiome-associated metabolites with significantly altered abundance in patients with CRC and adenoma. The ability of these metabolites to discriminate between CRC and colorectal adenoma was tested by targeted metabolomic analysis. A model based on gut microbiome-associated metabolites was established and evaluated in an independent validation cohort.ResultsIn total, 885 serum metabolites were significantly altered in both CRC and adenoma, including eight gut microbiome-associated serum metabolites (GMSM panel) that were reproducibly detected by both targeted and untargeted metabolomics analysis and accurately discriminated CRC and adenoma from normal samples. A GMSM panel-based model to predict CRC and colorectal adenoma yielded an area under the curve (AUC) of 0.98 (95% CI 0.94 to 1.00) in the modelling cohort and an AUC of 0.92 (83.5% sensitivity, 84.9% specificity) in the validation cohort. The GMSM model was significantly superior to the clinical marker carcinoembryonic antigen among samples within the validation cohort (AUC 0.92 vs 0.72) and also showed promising diagnostic accuracy for adenomas (AUC=0.84) and early-stage CRC (AUC=0.93).ConclusionGut microbiome reprogramming in patients with CRC is associated with alterations of the serum metabolome, and GMSMs have potential applications for CRC and adenoma detection.


2017 ◽  
Author(s):  
Talima Pearson ◽  
J. Gregory Caporaso ◽  
Monica Yellowhair ◽  
Nicholas A. Bokulich ◽  
Denise J. Roe ◽  
...  

AbstractObjectiveWe previously reported that Ursodeoxycholic acid (UDCA), a therapeutic bile acid, reduces risk for advanced colorectal adenoma in men but not women. Interactions between the gut microbiome and fecal bile acid composition as a factor in colon cancer neoplasia have been postulated but evidence is limited to small cohorts and animal studies.DesignUsing banked stool samples collected as part of a phase III randomized clinical trial of UDCA for the prevention of colorectal neoplasia, we compared change in the microbiome composition after 3 years intervention in a subset of participants randomized to 8–10 mg/kg of body weight UDCA (n=198) to placebo (n=203). UDCA effects on the microbiome, sex and adenoma outcome were investigated.ResultsStudy participants randomized to UDCA experienced compositional changes in their microbiome that were statistically more similar to other individuals in the UDCA arm than to those in the placebo arm. This change reflected an UDCA-associated shift in microbial community distance metrics (P <0.001), independent of sex, with no evidence of UDCA effect on microbial richness (P > 0.05). These UDCA-associated shifts in microbial community distance metrics from baseline to end-of-study were not associated with risk of any or advanced adenoma (all P> 0.05) in men or women.ConclusionDespite a large sampling of randomized clinical trial participants, daily UDCA use only modestly influenced the relative abundance of microbial species in stool with no evidence for effects of UDCA on stool microbial community composition as a modifier of colorectal adenoma risk.SUMMARYWhat is already known about this subject?Ursodeoxycholic acid (UDCA) is a therapeutic bile acid used in the treatment of primary biliary cirrhosis (PBC) and investigated for anti-cancer activity in the colonIn humans, UDCA is produced in the colon from the conjugation of primary bile acids by intestinal bacteriaIntestinal bacteria play a critical role in human intestinal health and disease including a hypothesized role in the development of colorectal cancer.UDCA was found to reduce the risk of more advanced colorectal adenoma with effects present in men but not women.Therapeutic UDCA was recently shown to reduce the extent of bacterial dysbiosis in patients with PBCWhat are the new findings?Among a population of patients with colorectal adenoma, low dose oral UDCA taken daily produced modest changes in fecal bacterial compositionUDCA associated changes in the gut microbiome were similar in men and women.UDCA associated changes in the gut micobiome were not associated with risk of any or advanced colorectal adenoma in the patient population.How might it impact on clinical practice in the foreseeable future?These findings confirm effects of oral UDCA on the microbiome that may be beneficial for patients with PBC.These findings suggest that the anti-cancer effects of UDCA for colorectal adenoma prevention are not due to major effects of UDCA on the gut microbiome.


2018 ◽  
Vol 73 (Suppl. 3) ◽  
pp. 17-23 ◽  
Author(s):  
Silvia Arboleya ◽  
M. Suárez ◽  
N. Fernández ◽  
L. Mantecón ◽  
G. Solís ◽  
...  

Background: The human gut microbiota is assembled during infancy with an increase in diversity and stability. The correct colonization and the establishment of this microbiome are linked to the early and future health status of the individual. It is known that caesarean delivery alters this optimal microbial foundation. C-section (CS) is a common obstetrician surgery; however, it is not without risk for the mother/infant dyad. The World Health Organization recommends not exceeding 10–15% of the total deliveries; nevertheless, this rate has been increasing rapidly worldwide in the last decades. Summary: This review discloses the clinical parameters for correct CS recommendation. Moreover, the major microbial changes in the infant gut microbiome acquisition as a consequence of delivery mode and medical practices surrounding it, as well as, the early and long-lasting effects for both mother and babies are discussed. In addition, some strategies for the gut microbiota restoration are analysed. The aim of this review is to show the need for the development of strategies for minimizing or limiting the impact of caesarean on the microbiome development, favouring future health.


Sign in / Sign up

Export Citation Format

Share Document